DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Eri LM, Urdal P, Bechensteen AG.
Effects of the luteinizing hormone-releasing hormone agonist leuprolide on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasia.
J Urol 1995; 154: 100-104
We do not assume any responsibility for the contents of the web pages of other providers.